Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2026-05-12
DOI
https://doi.org/10.1111/apt.70715
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply

Cristina Suárez-Ferrer, Yamile Zabana, the Young Group of GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis), José Luis Rueda García
Alimentary Pharmacology & Therapeutics
Inflammatory Bowel Disease
article

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply

Cristina Suárez-Ferrer, Yamile Zabana, the Young Group of GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis), José Luis Rueda García
article en

Abstract

No abstract available for this paper.
Alimentary Pharmacology & Therapeutics
Hospital Universitario La Paz (ES), Hospital La Paz Institute for Health Research (ES), Mútua Terrassa (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
Quality Education
Openalex Percentile: Top 6%
Inflammatory Bowel Disease
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.